Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b0f5fa6606feb99cbc8561777ca3299 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J2389-06 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L89-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J3-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L89-06 |
filingDate |
2001-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97ed6adc611001f57ee564655e363c31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d518d285775ef3403641bdac8658b67 |
publicationDate |
2005-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1541634-A1 |
titleOfInvention |
Process for the preparation of micronised collagen, and its therapeutic applications |
abstract |
Non-denatured triple-helix collagen extracted from animal tendons and skin is purifiednand brought into the form of a stable, sterile and meterable powder having anparticle size of not more than 20 microns. n The powdered collagen so obtained has favourable characteristics of distributionnand asepsis and is particularly efficacious in the more delicate phases of thenwound-healing process compared with powdered collagens obtained by knownnmethods. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013108870-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103906794-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013066812-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9051439-B2 |
priorityDate |
2000-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |